Type 2 diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: type 2 diabetic patients medicated with basal+bolus therapy (insulin glulisine+ insulin glargine 300 U/ml) for 3 month or longer
Exclusion criteria
Exclusion criteria: Patients with severe renal dysfunction (serum creatinine level more than 2.0 mg/dL) Patients who were aware that they were hypoglycemic and took glucose tablets Patients considered not suitable for participation due to medical reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 08:00 to 24:00 percentage of time in target range (70~140 mg/dL) | — |
Secondary
| Measure | Time frame |
|---|---|
| 08:00 to 24:00 mean absolute glucose (MAG) 08:00 to 24:00 glycemic variability percentage (GVP) 08:00 to 24:00 mean glucose level 08:00 to 24:00 standard deviation (SD) 08:00 to 24:00 coefficient of variation (CV) Highest postprandial glucose level within 3 hours after each meal Differences between preprandial and highest postprandial glucose level for each meal Post-breakfast glucose gradient AOC (<70 mg/dL) for glycemic variability (0:00~8:00, 8:00~12:00, 12:00~18:00, 18:00~24:00) M-value (8:00~24:00,24h) MAGE ADRR Time from start of meal to the highest postprandial glucose level MODD 08:00 to 24:00 low blood glucose index (LBGI) | — |
Countries
Japan
Contacts
General Inuyamachuo Hospital Department of Diabetes